FPS
MRNA icon

Fieldpoint Private Securities’s Moderna MRNA Stock Holding History

Fieldpoint Private Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$18K Sell
124
-90
-42% -$12.9K 0.01% 626
2022
Q1 		$37K Buy
214
+109
+104% +$18.4K 0.01% 667
2021
Q4 		$27K Buy
105
+85
+425% +$24.9K 0.01% 785
2021
Q3 		$8K Buy
20
+15
+300% +$5.53K ﹤0.01% 1120
2021
Q2 		$2K Buy
+5
New +$894 ﹤0.01% 1397

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fieldpoint Private Securities's MRNA Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Moderna (MRNA) stake by 42% in Q2 2022, selling an estimated $12.9K and leaving 124 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #626.

Fieldpoint Private Securities first reported a position in MRNA in Q2 2021 and has held it in 5 quarters since. The position peaked at $37K in Q1 2022. 982 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Fieldpoint Private Securities held 124 shares of Moderna worth $18K as of Q2 2022.
  • Fieldpoint Private Securities sold 90 Moderna shares in Q2 2022, an estimated $12.9K.
  • Moderna made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #626 holding.
  • Fieldpoint Private Securities first reported a position in Moderna in Q2 2021 and has held it in 5 quarters since.
  • Fieldpoint Private Securities's Moderna position peaked at $37K in Q1 2022.
  • 982 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.